Ann: Notification regarding unquoted securities - IPD, page-2

First Baseline Date: The First Baseline Date is the grant date of the Performance Rights, which will be the earlier to occur of
the date that is (i) 5 Business Days after public disclosure by ImpediMed regarding the NCCN review of the Survivorship
Committee submission or (ii) 1 April 2023, but in any event after the Meeting.

So a very dour conference call - can anybody think why? lol

Still this is very intelligent of the board to structure the incentive in this fashion - have to give credit for that! So I guess the grant price is 10.5c. A good price considering that big binary is resolved more favourably than expected, with general cancer rather than just Breast Cancer.